Carl Blackman of the U.S. EPA has published an editorial comment accompanying the new Boris Pasche paper on modulating frequencies to treat cancer in the British Journal of Cancer. In "Treating Cancer with Amplitude-Modulated Electromagnetic Fields: A Potential Paradigm Shift, Again?," Blackman puts Pasche's new findings in context with the work on amplitude-modulated (AM) signals by Ross Adey and Suzanne Bawin from the mid-1970s, as well as Blackman's own studies from the same era. Blackman concludes: "The group of [Pasche's] three papers demonstrate a new, potentially important modality in the treatment of cancer that could lead to a paradigm shift in disease treatment. I hope that this medical application of AM-EMF will not be allowed languish without funding, as happened with its previous, ill-fated emergence." The editorial is open access, as is the Pasche paper.
Return to Short Takes Archive
